Close
The page header's logo
Help
Login
Staff Login
Register
0
Selected 
Invert selection
Deselect all
Deselect all
 Add to Cart
 Click here to refresh results
 Click here to refresh results
Go to Login page
 Hide details
doctype icon
Conceptually similar
FDA approves party drug to treat depression
Mp4
play button
CP12032239 | FDA approves party drug to treat depression 
FDA approves first drug to treat peanut allergies
play button
CP16634921 | FDA approves first drug to treat peanut allergies 
FDA 'looking at everything' to treat virus
play button
CP17026771 | FDA 'looking at everything' to treat virus 
FDA approves Alzheimer’s drug debated by experts
play button
CP124770498 | FDA approves Alzheimer’s drug debated by experts 
Fauci: Johnson vaccine likely to get FDA approval
play button
CP116464160 | Fauci: Johnson vaccine likely to get FDA approval 
Pentagon: Mandatory vaccinations after FDA approval
play button
CP130275122 | Pentagon: Mandatory vaccinations after FDA approval 
FDA to improve access to experimental cancer drugs
Mp4
play button
CP12039606 | FDA to improve access to experimental cancer drugs 
Hopes and hype for ketamine to treat depression
Mp4
play button
CP12086995 | Hopes and hype for ketamine to treat depression 
FDA approves boosters for all US adults
play button
CP141800521 | FDA approves boosters for all US adults 
FDA approves new painkiller that shows promise and challenges of opioid alternatives
play button
CP174009994 | FDA approves new painkiller that shows promise and challenges of opioid alternatives 
Action button

FDA approves drug to treat postpartum depression

The U.S. Food and Drug Administration has approved the first drug specifically developed to treat postpartum depression. The agency on Tuesday approved Sage Therapeutics' Zulresso, a physician administered IV drug given over 2 ½ days. (March 20) 
Actions
 Add to collection
 Add to cart
Information
Source name: 
The Associated Press
Unique identifier: CP12032898 
Legacy Identifier: 19eb60f2e96b404686b46a3cc81b7569 
Type: Video 
Duration: 2m25s 
Dimensions: 1920px × 1080px     178.17 MB 
Usage rights: Digital platform use only. Broadcast rights and editing of content prohibited. 
Create Date: 3/20/2019 8:07:36 PM 
Display aspect ratio: 16:9